Outcomes After Post-Traumatic AKI Requiring RRT in United States Military Service Members

Abstract

Background and objectives

Mortality and CKD risk have not been described in military casualties with post-traumatic AKI requiring RRT suffered in the Iraq and Afghanistan wars.

Design, setting, participants, & measurements

This is a retrospective case series of post-traumatic AKI requiring RRT in 51 military health care beneficiaries (October 7, 2001–December 1, 2013), evacuated to the National Capital Region, documenting in-hospital mortality and subsequent CKD. Participants were identified using electronic medical and procedure records.

Results

Age at injury was 26±6 years; of the participants, 50 were men, 16% were black, 67% were white, and 88% of injuries were caused by blast or projectiles. Presumed AKI cause was acute tubular necrosis in 98%, with rhabdomyolysis in 72%. Sixty-day all-cause mortality was 22% (95% confidence interval [95% CI], 12% to 35%), significantly less than the 50% predicted historical mortality (P<0.001). The VA/NIH Acute Renal Failure Trial Network AKI integer score predicted 60-day mortality risk was 33% (range, 6%–96%) (n=49). Of these, nine died (mortality, 18%; 95% CI, 10% to 32%), with predicted risks significantly miscalibrated (P<0.001). The area under the receiver operator characteristic curve for the AKI integer score was 0.72 (95% CI, 0.56 to 0.88), not significantly different than the AKI integer score model cohort (P=0.27). Of the 40 survivors, one had ESRD caused by cortical necrosis. Of the remaining 39, median time to last follow-up serum creatinine was 1158 days (range, 99–3316 days), serum creatinine was 0.85±0.24 mg/dl, and eGFR was 118±23 ml/min per 1.73 m². No eGFR was <60 ml/min per 1.73 m², but it may be overestimated because of large/medium amputations in 54%. Twenty-five percent (n=36) had proteinuria; one was diagnosed with CKD stage 2.

Conclusions

Despite severe injuries, participants had better in-hospital survival than predicted historically and by AKI integer score. No patient who recovered renal function had an eGFR<60 ml/min per 1.73 m² at last follow-up, but 23% had proteinuria, suggesting CKD burden.

Introduction

Mortality and CKD risk have not been reported in American military casualties with post-traumatic AKI (PTAKI) requiring RRT suffered in the Iraq and Afghanistan wars. PTAKI-associated mortality in casualties requiring RRT has been 63%–75% since the Korean conflict (1,2). Although mortality is unchanged, casualties are increasingly severe, associated with improved resuscitation, surgical, and evacuation capabilities (3–9). Civilian mortality is similar at 36%–73% (10–13). In Korea and Vietnam, survivors were reported to recover fully, but follow-up was sparse, and quantification of renal function not available. In civilian series, most do not require dialysis at discharge; however, in one cohort, 27% had not normalized serum creatinine (sCr) (11). Because even a single episode of AKI may increase future CKD risk, patients with PTAKI requiring RRT who recover renal function may be at risk for subsequent CKD, with associated morbidity and mortality (14–16). We performed a retrospective case series of United States military casualties from the Iraq and Afghanistan wars with PTAKI requiring RRT, ultimately evacuated to the National Capital Region, describing 60-day and long-term mortality, ESRD incidence, and CKD incidence. Observed mortality was compared to historic mortality for military and civilian PTAKI patients requiring RRT and to mortality predicted by the VA/NIH Acute Renal Failure Trial Network AKI integer risk score, developed in critically ill patients who received RRT for AKI (17,18). We hypothesized that this young, healthy cohort would have lower mortality than historically reported, and evidence of CKD in long-term follow-up.

Materials and Methods

Participants were male and female military health care beneficiaries ≥18 years with PTAKI requiring RRT resulting from injuries sustained during the Iraq or Afghanistan wars from October 7, 2001–December 1, 2013, managed at one of the hospitals with RRT support in the National Capital Region. (Before September 2011 these were Walter Reed Army Medical Center [WRAMC] in Washington, DC, and National Naval Medical Center in Bethesda, Maryland. In September 2011, these were consolidated into one hospital—Walter Reed National Military Medical Center (WRNMMC) in Bethesda, Maryland.) Trauma was defined as an externally applied injury, which preceded and precipitated AKI. Those who had burns requiring subspecialty burn unit care were excluded and have been reported separately (6).

Potential participants were identified by searching the WRNMMC Cache transactional database (InterSystems, Vienna, VA), which included inpatient (Essentris) and outpatient (Composite Health Care System (CHCS)/AHLTA) electronic medical records. Essentris inpatient records were distinct for each hospital (WRAMC and National Naval Medical Center) before September 2011 and integrated afterward. Outpatient records were available through the single CHCS/AHLTA system throughout the time period. We used International Classification of Diseases, 9th Revision (ICD9) codes for acute renal failure, dialysis-associated Current Procedural Terminology (CPT) codes, nephrology and dialysis clinic identifiers, appointment categories, demographic identifiers (age and active duty status), Defense Enrollment Eligibility Reporting System eligibility dates, and the WRAMC/WRNMMC nephrology procedure log (documenting continuous RRT [CRRT] and dialysis catheter placement) to identify potential participants.

There were 741 individual admission records screened by four investigators (J.A.B., C.M.Y., D.J.L., and S.W.O.) for inclusion and exclusion criteria. Fifty-one patients meeting criteria were entered into the study. Individual data collection sheets were populated by one investigator (K.C.A., C.M.Y., and J.A.B.), and entries were verified by a second investigator (C.M.Y. and D.J.L.). Data were obtained from Essentris and AHLTA electronic medical records, which include clinical records from military theater, including Landstuhl Regional Medical Center (LRMC), Veterans’ Administration outpatient clinics, and other United States–based military medical facilities. Follow-up was through January 1, 2014. Deidentified data were entered into an Excel spreadsheet for analysis.

Sixty-day all-cause mortality was defined as death by day 60 after beginning RRT, whether before or after hospital discharge (17). The VA/NIH Acute Renal Failure Trial Network AKI integer risk score was manually calculated using the arithmetic sum of points for each of 21 parameters, and 60-day mortality risk was determined (18). Two patients, both of whom died, did not have sufficient data for integer risk score calculation.

All participants were seen in consultation by nephrology (intensivists did not independently provide RRT in the National Capital Region). Clinical diagnosis of AKI cause(s) recorded at the time of consultation was used as the diagnosis, unless subsequent biopsy (one subject) indicated otherwise. RRT initiation date was determined from in-theater, LRMC, or National Capital Region medical records, dialysis treatment records, and transfer summaries. RRT indication(s) was that recorded by the provider at initiation. The latest recorded sCr was used to determine eGFR using the Chronic Kidney Disease Epidemiology Collaboration formula. Proteinuria was assessed using the latest recorded urinalysis, urine protein/creatinine ratio, or 24-hour urine protein, if available. Proteinuria was deemed present if >150 mg protein/g creatinine, >150 mg protein/24 hours, or ≥1+(30 mg/dl) protein on urine dipstick. Hypertension (HTN) was identified on the basis of a diagnosis in follow-up with or without antihypertensive therapy. Normal BP was deemed present if the last 2–3 BP determinations were <140/90 mmHg in a subject not receiving antihypertensive medication. ESRD was defined as the requirement for permanent RRT (including transplant) at last follow-up. CKD was defined to be present if eGFR was <60 ml/min per 1.73 m², proteinuria was present as previously defined, or if the patient had a diagnosis of CKD, ESRD, or kidney transplant at last follow-up (19).

Amputation was defined as small (one or less trans-knee amputation); medium (bilateral trans-knee amputation or unilateral above-the-knee amputation with or without a trans-knee amputation); or large (bilateral above-the-knee amputation or higher) (20). Date and cause of injury and details of initial trauma were determined from in-theater and LRMC transfer summaries and arrival history. Number of units of packed red blood cells administered before arrival in the National Capital Region was determined from in-theater and LRMC transfer summaries and admission history. The estimated number of surgeries from the time of injury to death or discharge was determined from in-theater and LRMC transfer summaries, admission, discharge, and death summaries. Outpatient serum calcium, phosphate, and hemoglobin were the latest available. Maximum creatine phosphokinase was the highest creatine phosphokinase (units/L) recorded before RRT initiation.

Data are presented as mean±SD or as median (range). Descriptive statistics and transformations were performed in Excel. Comparisons were made using t test or Fisher exact test (QuickCalcs, GraphPad Software; available at: http://www.graphpad.com/quickcalcs/). Data not normally distributed were transformed as described in the text and tables before use of t test. A P value <0.05 was considered to be significant. AKI integer score–estimated mortality risk for those who died within 60 days versus those who survived was compared using the Wilcoxon rank-sum test (STATA 12.1; StataCorp, College Station, TX). Observed 60-day mortality was compared with expected historical mortality of 50% (the lower range of historical reports for military casualties with PTAKI requiring dialysis, and the weighted average mortality observed in more recent civilian case series [10–13]) (binomial distribution; QuickCalcs). It was also compared with AKI integer score–estimated mortality risk using the Hosmer–Lemeshow goodness of fit test in the 49 participants who had sufficient information to calculate the score (programmed in R by S.R.H.; available at: http://www.r-project.org, using the Resource Selection package from CRAN, for five subgroups and tested for stability from three to ten subgroups [Supplemental Material 1]) (21). Sensitivity analysis was performed by adding two fictional patients (accounting for those who were excluded from analysis because of insufficient data), with predicted mortality risk drawn from 0% to 100% in 1% increments (Supplemental Material 2). Receiver operator characteristic (ROC) analysis assessing performance of the AKI integer score estimation of mortality risk (in the same 49 patients) versus performance of the AKI integer risk score as reported in Figure 2 of Demirjian et al. (18) was also programmed in R (S.R.H.), using the pROC package from CRAN (22). ROC curves include 95% bootstrap confidence bands, with the area under the curve (AUC) reported with 95% confidence interval [95% CI] confidence, and the two AUCs were compared by the method of DeLong et al. (23). Kaplan–Meier survival estimate analysis in all 51 participants was performed in STATA 12.1 (C.M.Y.).

Figure 2.

Receiver operator characteristic analysis of 49 participants in whom AKI integer score mortality risk could be determined versus reference AKI integer score cohort (18). The area under the curve (C-statistic) was 0.72 (95% confidence interval, 0.56 to 0.88) for the National Capital Region cohort. The 95% confidence bands are shown for both curves, and they were not significantly different (P=0.27). Model cohort, reference AKI integer score cohort; NCR cohort, participants in whom AKI integer score mortality risk could be determined.

The WRNMMC Institutional Review Board approved the study (#394030) as minimal risk, with waiver of informed consent, and adherent to the Declaration of Helsinki. The manuscript was approved by the WRNMMC Department of Research Programs and Office of Public Affairs.

Results

Demographic features and clinical characteristics of initial injury, hospital course, and RRT are shown for the 51 participants (Table 1). Participants were predominantly men, aged 26±6 years. Of these, 88% were injured by explosive devices or projectiles, and 98% required ventilator support. Seventy-five percent had bacteremia with at least one organism, and 35% had bacteremia with >1 organism. There were 18% that had Acinetobacter bacteremia, and 12% had mucormycosis. Seventy-one percent ultimately experienced amputation.

Table 1.

Demographics and characteristics of wounded warriors requiring RRT for AKI managed in the National Capital Region (n=51)

Characteristic	Value
Demographic features
Age at injury (y)	26±6
Sex, male:female	50:1
Race
White	34 (67)
Black	8 (16)
Other	9 (18)
Injury features
Type of injury
IED	35 (69)
GSW	6 (12)
Rocket/RPG/mortar	4 (8)
Poisoning	3 (6)
Immobilization trauma	2 (4)
Cardiac arrest/shock	1 (2)
Rhabdomyolysis	2 (4)
Postconcussive seizures	1 (2)
Physical assault/ingestion	1 (2)
Vehicular	1 (2)
Units of PRBCs downrange (n=47)	24 (0–200)
Estimated surgeries until death or discharge	10 (0–36)
Amputation	36 (71)
Maximum CPK (n=49) (units/L)	14,550 (155–1,900,000)
Urinary tract trauma/injurya	24 (47)
Kidney(s)	5 (20)
Ureter(s)	5 (20)
Bladder	12 (50)
Urethra	14 (58)
Total hospital days in National Capital Region	51 (6–312)
Clinical features of AKI
Presumed Cause of AKIb
ATN	50 (98)
Sepsis/hypotension	46 (92)
Rhabdomyolysis	36 (72)
IV contrast	3 (6)
Cortical necrosis (by biopsy)	1
60-d mortality	11 (22)
Death on RRT	8 (16)
Days from injury to RRT	4 (1–66)
Dialysis initiated before reaching CONUS	30 (59)
Serum creatinine at initiation (n=49) (mg/dl)	5.58±2.85
AKI integer score (n=49)	22 (14–37)
Probability of death from AKI integer score (%)	33 (6–96)
ESRD	1 (2)
Indications for dialysisc
Hyperkalemia	35 (69)
Volume overload	25 (49)
Acidosis	23 (45)
Azotemia	26 (51)
Other	2 (4)
Days on RRT to death or recovery (n=50)	17 (1–51)
RRT treatments per week	5.0±1.4
RRT modalities: 31 (61%) were treated with >1 modality
iHD	50 (98)
SLEDD	25 (49)
CRRT	13 (26)
PD	0 (0)
Serum creatinine at hospital discharge (n=40) (mg/dl)	1.03±1.51
On dialysis at hospital discharge (n=40)	1 (2.5)

Data are presented as mean±SD, median (range), or count (%). IED, improvised explosive device; GSW, gunshot wound; RPG, rocket-propelled grenade; PRBCs, packed red blood cells; CPK, creatine phosphokinase; IV, intravenous; CONUS, continental United States; iHD, intermittent hemodialysis; SLEDD, slow low efficiency daily dialysis; CRRT, continuous RRT; PD, peritoneal dialysis.

^aIndividual patients could have more than one site of urologic injury.

^bIndividual patients with clinical acute tubular necrosis could be assigned more than one potential etiology.

^cIndividual patients could have more than one indication for RRT.

Urologic trauma occurred in 47%; most commonly this was bladder and urethral. There were 50 patients who had clinically diagnosed acute tubular necrosis; 72% with concurrent rhabdomyolysis. One patient did not recover function, had biopsy-proven cortical necrosis, and was successfully transplanted.

Median time to RRT from initial injury was 4 days. Hyperkalemia was the most frequent indication. RRT was initiated before arrival in the United States in 30 patients; 26 began RRT at LRMC. Median time on RRT to death or recovery was 17 (range, 1–51) days. The number of RRT treatments per week was 5.0±1.4. Intermittent hemodialysis was used in 98%, slow low efficiency daily dialysis was used in 49%, and CRRT was used in 28%. No patient received peritoneal dialysis.

On Kaplan–Meier survival analysis, median follow-up time from date of injury was 987 days (range, 14–3318 days), or 2.7 years. Twelve died, one at 605 days after injury. Of the remaining 11 patients, all of whom died within 60 days of dialysis initiation, median time from injury to death was 20 days (range, 14–55 days), and median time from dialysis initiation to death was 12 days (range, 1–54). Sixty-day mortality was 22% (95% CI, 12% to 35%), significantly less than the predicted historical mortality of 50% (P<0.001, binomial distribution). AKI integer score–predicted median mortality risk was 33% (range, 6%–96%), among the 49 participants with sufficient data to calculate the score. Nine of these 49 patients died, yielding a 60-day mortality of 18% (95% CI, 10% to 32%). Predicted risks were significantly miscalibrated (H-statistic 19.3, 3 df, P<0.001). The validation plot of observed versus predicted mortality for the AKI integer score is shown in Figure 1, demonstrating predicted mortality diverged from observed mortality. Sensitivity analysis showed inclusion of two additional patients would not substantially affect significance (P=0.005, worst-case scenario). The area under the ROC curve (Figure 2) for the AKI integer score in our cohort was 0.72 (95% CI, 0.56 to 0.88), not significantly different than that observed for the model cohort developed from the VA/NIH Acute Renal Failure Trial Network study (P=0.27) (17,18).

Figure 1.

Observed versus predicted 60-day mortality in 49 participants in whom AKI integer score mortality risk could be determined. (Hosmer–Lemeshow goodness of fit test with five subgroups [3 df]: H-statistic 19.3; P<0.001). Vertical bars indicate 95% confidence interval.

Of the 40 survivors, 32 had outpatient follow-up through January 1, 2014. Seven had a last follow-up date of late July 2013–December 31, 2013. One patient died 1 year after hospital discharge, of unknown causes. Table 2 shows the demographic characteristics of the survivors and their follow-up course. Age at last follow-up was 29±6 years, and median time from injury to last follow-up was 1326 (range, 219–3318) days, or 3.63 years.

Table 2.

Follow-up clinical characteristics of wounded warriors requiring RRT for AKI managed in the National Capital Region who survived hospitalization (n=40)

Demographic Features		Value
Age at injury (y)		25±5
Age at last follow-up (y)		29±6
Death during follow-up		1 (2.5)
Time from injury to last follow-up (d)		1326 (219–3318)
Sex, male:female		39:1
Race
White		26 (65)
Black		8 (15)
Other		6 (20)
ESRD (present at hospital discharge)		1 (2.5)
Kidney function (n=39, without ESRD at hospital discharge)
Serum creatinine at hospital discharge (mg/dl)		0.80±0.36
Time from injury to last serum creatinine (d)		1158 (99–3316)
Serum creatinine at last follow-up		0.85±0.24
eGFR (CKD-EPI) at last follow-up (ml/min per 1.73 m2)		118±23
eGFR≤60 ml/min per 1.73 m2		0 (0)
HTN present at last follow-up		8 (21)
Proteinuria present at last follow-up (n=36)		9 (25)
Calcium at last follow-up (n=32) (mg/dl)		9.6±0.7
Phosphate at last follow-up (n=13) (mg/dl)		3.7±0.9
Hemoglobin at last follow-up (n=26) (g/dl)		13.8±2.4
Nephrolithiasis by history or imaging		7 (18)
Neurogenic bladder		7 (18)
Amputation and Renal Function (n=39, without ESRD at hospital discharge)
Degree of Amputation	Serum Creatinine at Last Follow-Up (mg/dl)		eGFR (CKD-EPI) at Last Follow-Up (ml/min per 1.73 m2)
None (n=12)	0.86±0.30		117±27
Small (n=6)	1.00±0.18		107±20
Medium (n=8)	0.82±0.14		121±11
Large (n=13)	0.81±0.26		122±26

Data are presented as mean±SD, median (range), or count (%). CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; HTN, hypertension.

Of the 39 survivors not at ESRD, the time from injury to last sCr was 1158 (range, 99–3316) days; sCr was 0.85±0.24 mg/dl. None had an eGFR≤60 ml/min per 1.73 m², but four patients had an eGFR<80 ml/min per 1.73 m². Of the 36 patients who had a measurement, nine (25%) had proteinuria. Two had proteinuria quantified at ≥150 mg/24 h or per gram creatinine. The remainder had 30 mg/dl (n=3) or greater (n=4) on dipstick urinalysis. Of these, two patients had associated HTN, and one had an eGFR<80 ml/min per 1.73 m². This patient, the only one with a CKD diagnosis, had angiotensin receptor blocker–treated HTN, 266 mg proteinuria/24 h, and an eGFR of 74 ml/min per 1.73 m².

Of the patients, 69% (Table 2) had amputations; 13 (33%) of which were large (i.e., bilateral above-the-knee amputations or higher). Despite this loss of muscle mass and creatinine source, sCr and eGFR were not different in large amputees versus those without amputation (P=0.67 and P=0.60, respectively). This was also true for all amputees versus those with no amputation (P=0.97 and P=0.81, respectively). There were 18% who had nephrolithiasis by history or imaging and 18% who had neurogenic bladder, although of varying severity.

Table 3 compares demographic and clinical characteristics of those who died in-hospital versus those who survived. Those who died had significantly fewer hospital days (16±7 versus 90±70, P=0.001), surgical procedures, and days on RRT. They had more RRT treatments per week and lower sCr at RRT initiation (3.66±1.07 versus 6.01±2.96 mg/dl, P=0.01). AKI integer score mortality risk in participants who died was significantly greater than in survivors (44% [range, 18%–91%] versus 23% [range, 6%–96%], P=0.04; Wilcoxon rank-sum test); however, the score could be calculated in only nine of the 11 patients who died.

Table 3.

Comparison of demographic and clinical characteristics of wounded warriors requiring RRT for AKI managed in the National Capital Region on the basis of in-hospital mortality

Demographic Features	Survived (n=40)	Died (n=11)	P Value
Age at injury (y)	25±5	28±6	0.10
Sex (male)	39 (98)	11 (100)	>0.99
Race
White	26 (65)	8 (73)	0.73
Black	8 (20)	0 (0)	0.19
Other	6 (15)	3 (27)	0.39
Injury features
Type of injury (IED)	26 (65)	9 (81.8)	0.47
Units of PRBCs downrangea	24 (0–159)	26 (0–200)	0.32
Hospital days in National Capital Region	90±70	16±7	0.001
Estimated surgeries until death or discharge	13±9	7±3	0.04
Amputation	27 (68)	9 (82)	0.47
Maximum CPK (units/L)b	15,053 (155–200,000)	11,574 (691–1,900,000)	0.95
Clinical features of AKI
Presumed cause of AKI	ATN 39	ATN 11	>0.99
	Rhabdo 29	Rhabdo 7
	Other 1	Other 0
Days from injury to RRT	8±11	7±7	0.78
Serum creatinine at initiation	6.01±2.96	3.66±1.07	0.01
AKI integer scorec	20 (14–37) (n=40)	24 (19–34) (n=9)	0.04
Probability of mortality from integer scorec (%)	23 (6–96) (n=40)	44 (18–91) (n=9)	0.04
Indications for dialysis
Hyperkalemia	27 (68)	8 (73)	>0.99
Volume overload	21 (53)	4 (36)	0.50
Acidosis	17 (43)	6 (55)	0.51
Azotemia	22 (55)	4 (36)	0.32
Other	2 (5)	0 (0)	>0.99
Days on RRT	20±11	12±11	0.04
RRT treatments per week	4.7±1.1	6.0±1.2	0.001
RRT modality
iHD	39 (98)	11 (100)	>0.99
SLEDD	20 (50)	5 (46)	>0.99
CRRT	8 (20)	5 (46)	0.12
CRRT as initial RRT modality	6 (15)	4 (36)	0.19

Data are presented as mean±SD, median (range), count (%), or as otherwise indicated. IED, improvised explosive device; PRBCs, packed red blood cells; CPK, creatine phosphokinase; ATN, acute tubular necrosis; iHD, intermittent hemodialysis; SLEDD, slow low efficiency daily dialysis; CRRT, continuous RRT.

^aData were transformed using a square-root transformation before t test.

^bData were transformed using a log transformation before t test.

^cWilcoxon rank-sum test.

Discussion

In this retrospective case series of young, healthy military casualties with PTAKI requiring RRT during the Iraq and Afghanistan wars, 60-day mortality was 22% (95% CI, 12% to 35%), significantly less than the 63%–75% mortality reported during Korea and Vietnam (1–3,5,7–9). Participants were demographically similar to historical cohorts, but medical and surgical management have changed substantially, with increased number and severity of casualties surviving to receive definitive care (24). Potential explanations for improved survival include shorter evacuation times because of definitive air superiority and better resuscitation, surgery, and dialysis techniques (3,4,25–28). Casualties requiring specialized burn care, treated at San Antonio Military Medical Center, were not included. Stewart et al. reported 65% mortality among the burn casualties with AKI requiring RRT (6), and others have reported that PTAKI burn patients have higher mortality (13).

Civilian outcomes for PTAKI requiring RRT likely reflect improvements in medical and surgical capabilities, but they include few young patients without comorbidities. Observed mortality is approximately 40%–80% in civilian trauma series (10–12,29,30). Preexisting chronic conditions and increasing age have been associated with higher mortality in some series (10,12), However, Machemehl et al. reported mortality was independent of age, albeit in an older population with comorbidities (13). Among children in the Prospective Pediatric CRRT registry, mortality was 42%, but PTAKI was not a reported cause of AKI (31).

We used the VA/NIH Acute Renal Failure Trial Network AKI integer risk score (17,18) to compare observed versus expected mortality in the 49 participants in whom it could be calculated. Median mortality risk predicted by the AKI integer risk score was significantly greater than observed mortality. Although the integer score differentiated between survivors and those who died within 60 days of RRT initiation, it was significantly miscalibrated. The ROC curve developed in our cohort was not significantly different than that of the original model cohort (17,18). To our knowledge, this is the first study using the AKI integer score to predict mortality risk. Although mortality estimates for our cohort were miscalibrated, the integer score performed reasonably well, especially because the model cohort was older (59.7±15.3 years) and had multiple comorbidities. The maximum AKI integer score possible is 59, with four parameters (age >50 years, chronic hypoxemia, malignancy, and cardiovascular disease) contributing a maximum 14 points. None of the participants in our cohort received these points. The maximum possible score was 45; the maximum observed score was 37.

All but one of the survivors (98%) recovered renal function and discontinued dialysis. Renal recovery was similar to that previously reported in military casualties (1–3,5,7–9). In civilian series, >90% of patients recover renal function before discharge, even though many had comorbidities that increased ESRD risk (10–12,14,29,30).

Even one episode of AKI is associated with future CKD risk; however, few, if any, studies describe CKD incidence in young, healthy persons without preexisting comorbidities or underlying kidney disease after AKI requiring RRT (15,16,32–34). In children who survived neonatal extracorporeal membrane oxygenation-associated AKI, 32% had evidence of mild CKD (35). Of the survivors in our cohort, 23% had proteinuria in follow-up; however, urine protein quantification may not have been done in first-morning void specimens and therefore may overestimate albuminuria prevalence (36). One survivor had diagnosed stage 2 CKD with proteinuria and eGFR<80 mg/min per 1.73 m². Some of the amputees may have undiagnosed CKD, despite apparently normal eGFR. Creatinine-based eGFR is inaccurate after amputation, overestimating function (20).

Ninety-eight percent were treated with intermittent hemodialysis; however, many also received slow low efficiency daily dialysis and/or CRRT. Peritoneal dialysis was not used, consistent with previous experience (37). The most common RRT indication was hyperkalemia (69%), followed by azotemia (51%), volume overload (49%), and acidosis (45%). This was consistent with the clinical situation—rhabdomyolysis, large-volume resuscitation with blood products (38,39), hypercatabolism, and frequent (often daily) surgery. Often, RRT was required within days of initial injury; 59% required initiation before reaching the United States. Intensity was high, particularly early on: 5.0±1.4 treatments per week overall. CRRT, as an initial RRT modality, was not associated with survival.

As a case series, similar to all previous reports, our study is descriptive, not permitting definitive statistical inferences. There is no internal comparison group, and historical comparisons cannot account for potential confounding variables. The number of participants is small. It is, however, the only report of the characteristics and long-term outcomes of PTAKI-associated RRT for the nation’s longest war. It is difficult to study AKI in randomized controlled trials, and prospective cohort studies (40,41) include few patients with PTAKI and few young patients. Our data do not allow determination of PTAKI incidence. Non-RRT requiring PTAKI was not studied. The Combat Casualty Critical Care database contains 6011 critically injured combat casualties who required intensive care unit admission and survived to be evacuated from Iraq or Afghanistan to the LRMC between 2002 and 2011 and may yield further information on PTAKI and associated RRT (42). The study of PTAKI will continue to rely on observational analyses, which can inform the design of much-needed prospective trials. The AKI integer risk score supplied a predicted mortality risk not dependent on historic reports. We suggest its routine use in future case series.

In summary, mortality in this young and otherwise healthy cohort with PTAKI requiring RRT was 22%, significantly less than historically predicted. Mortality predicted by AKI integer risk score was closer to that observed, but it is still an overestimate (18). Renal recovery occurred in 98% of survivors, but residual mild CKD is likely, with 23% having proteinuria at last follow-up, and creatinine-based eGFR is likely overestimated in amputees (20). Our observations are pertinent to civilian patients with similar demographics and may inform prognosis.

Disclosures

None.